drugset / Trial / NCT02638584

Effects of Ilaprazole on Ulcer Healing Rate and Prevention of Gastrointestinal Bleeding in the Patients Undergone ESD.

NCT02638584 ↗

Phase 4 Completed 176 enrolled Il-Yang Pharm. Co., Ltd.
RandomizedParallel-groupOpen-labelTreatment

Summary

This study compared Ulcer healing rate of Ilaprazole 20mg or Rabeprazole 20mg in the patients undergone Endoscopic Submucosal Dissection for Gastric Adenoma or Early Gastric Cancer and investigated Prevention of gastrointestinal bleeding.

Timeline

Start
2015-12
Primary completion
2018-03
Completion
2018-03

Outcome

Missed primary endpoint

paper There was no significant difference in the ulcer healing rate (ilaprazole vs. rabeprazole, 97.4% vs. 97.0 p = 0.78 at 4 weeks PMID 30167954 ↗

paper 100% vs. 100%, p = 0.95 at 8 weeks in the mITT analysis PMID 30167954 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Ilaprazole Small molecule 20 mg Oral
Comparator Rabeprazole Small molecule 20 mg Oral

Indications